Skip to main content

Browse Clinical Trials (807 trials open to new patients)

Cancer (795 trials open to new patients)

Acute Lymphoblastic Leukemia (22) Acute Myeloid Leukemia (37) Adenocarcinoma (2) Adrenal Cortex Carcinoma (2) Anal Basaloid Carcinoma (1) Anal Canal Cloacogenic Carcinoma (1) Anal Cancer (5) Angiosarcoma (1) Astrocytoma (27) Atypical Teratoid Rhabdoid Tumor (2) Basal Cell Carcinoma (3) Biliary Tract Cancer (5) Bladder Cancer (30) Bone Cancer (5) Brain and Central Nervous System Tumor (1) Brain Metastases (5) Breast Cancer (97) Cancer, General (36) Cancer Prevention (1) Cancer Screening (1) Carcinoid Tumor (2) Carcinoma, Intraductal, Noninfiltrating (1) Cervical Adenosquamous Carcinoma (4) Cervical Cancer (18) Cholangiocarcinoma (11) Chordoma (2) Choriocarcinoma (3) CNS Tumor (2) Colon Cancer (8) Colorectal Cancer (47) Colorectal Tumor (1) Congenital Mesoblastic Nephroma (1) Digestive System Neuroendocrine Neoplasm (1) Endometrial Cancer (16) Ependymoma (8) Epithelioid Sarcoma (1) Esophageal Cancer (8) Esophageal Carcinoma (2) Estrogen Receptor Negative (4) Ewing Sarcoma (12) Extragonadal Embryonal Carcinoma (1) Fallopian Tube Cancer (9) Fibrolamellar Carcinoma (1) Gallbladder Cancer (1) Ganglioneuroblastoma (4) Gastroesophageal Junction Adenocarcinoma (3) Germ Cell Tumor (11) Gestational Trophoblastic Tumor (1) Glioblastoma (22) Glioma (47) Gliosarcoma (3) Head and Neck Cancer (35) Head and Neck Squamous Cell Carcinoma (21) Head and Neck Tumor (5) Hematologic Neoplasms (2) Hematological Malignancies (1) Hepatic Cancer (1) Hepatoblastoma (10) Hepatocellular Cancer (2) Hepatocellular Carcinoma (24) HER2 (30) Hodgkin's Lymphoma (45) Hypopharyngeal Carcinoma (2) Hypopharynx Cancer (1) Immunotherapy (20) INI1-negative Tumors (2) Kidney Cancer (32) Langerhans Cell Histiocytosis (10) Laryngeal Cancer (3) Leiomyosarcoma (1) Leukemia (76) Lip and Oral Cavity Cancer (2) Liposarcoma (1) Liver Cancer (28) Locally Advanced Malignant Solid Neoplasm (3) Locally Advanced Solid Neoplasm (1) Low Grade Lung Neuroendocrine Neoplasm (1) Lung Cancer (98) Lung Non-Small Cell Cancer (7) Lung Non-Small Cell Carcinoma (7) Lung Small Cell Carcinoma (2) Lung Tumor (3) Lymphoma (94) Malignant Central Nervous System Neoplasm (1) Malignant Germ Cell Neoplasm (1) Malignant Neoplasm (23) Malignant Neuroendocrine Carcinoma (Diagnosis) (1) Malignant Peripheral Nerve Sheath Tumor (1) Malignant Rhabdoid Tumor (2) Malignant Solid Neoplasm (22) Mantle Cell Lymphoma (7) Medulloblastoma (11) Melanoma (47) Meningioma (2) Merkel Cell Carcinoma (5) Mesothelioma (8) Metastatic Cancer (4) Metastatic Malignant Solid Neoplasm (8) Mixed Oligoastrocytoma (2) Mucinous Adenocarcinoma (1) Multiple Myeloma (19) Myelodysplasia (1) Myeloproliferative Neoplasms (7) Nasopharyngeal Cancer (4) Nasopharynx Cancer (1) Neoplasms (14) Neoplasm Metastasis (2) Neoplasm of Bone (1) Neoplasms by Histologic Type (1) Neoplasms by Site (2) Neoplasms, Colorectal (1) Neoplasms Pancreatic (1) Neuroblastoma (24) Neuroendocrine Carcinoma (1) Neuroendocrine Neoplasm (2) Neuroendocrine Tumor (5) Non Hodgkin Lymphoma (41) Non-Small Cell Lung Cancer (65) Oligodendroglioma (2) Oral Cavity Cancer (1) Oropharyngeal Cancer (1) Oropharyngeal (p16-Negative) Carcinoma (2) Oropharynx Cancer (2) Osteosarcoma (13) Ovarian Cancer (25) Ovarian Clear Cell Adenocarcinoma (4) Ovarian Embryonal Carcinoma (1) Ovarian Mucinous Adenocarcinoma (2) Ovarian Serous Adenocarcinoma (3) Ovarian Tumor (2) Pancreatic Cancer (32) Pancreatic Ductal Adenocarcinoma (2) PEComa (1) Pediatric Cancer (1) Penile Cancer (1) Peripheral Primitive Neuroectodermal Tumor (5) Peritoneal Cancer (7) Pheochromocytoma (1) Primary Peritoneal Serous Adenocarcinoma (2) Progesterone Receptor Negative (4) Prostate Cancer (74) Rectal Cancer (6) Refractory Cancer (1) Refractory Central Nervous System Neoplasm (10) Refractory Hepatoblastoma (4) Refractory Malignant Solid Neoplasm (17) Refractory Neoplasm (1) Renal Cell Carcinoma (23) Renal Medullary Carcinoma (1) Renal Pelvis Cancer (1) Renal Pelvis Neoplasms (2) Resistant Cancer (1) Rhabdoid Tumor (11) Rhabdomyosarcoma (12) Salivary Gland Cancer (2) Sarcoma (29) Selected Tumors With Rhabdoid Features (1) Seminoma (3) Skin Cancer/Melanoma (48) Soft Tissue Sarcoma (13) Solid Cancers (1) Solid Neoplasm (4) Solid Tumor (112) Squamous Cell Carcinoma (38) Squamous Intraepithelial Lesion (1) Stomach Cancer (21) Stromal Neoplasm (1) Synovial Sarcoma (3) T Cell Lymphoma (9) Teratoma (4) Testicular Cancer (1) Testicular Tumor (1) Thyroid Cancer (5) Thyroid Gland Carcinoma (5) Thyroid Gland Medullary Carcinoma (1) Transitional Cell Carcinoma (33) Treatment-Related Cancer (1) Unresectable Esophageal Carcinoma (1) Unresectable Gallbladder Carcinoma (1) Unresectable Solid Neoplasm (5) Ureter Cancer (1) Ureteral Neoplasms (2) Urethral Cancer (2) Urethral Neoplasms (2) Urinary Bladder Tumor (3) Urologic Neoplasms (2) Uterine Cancer (4) Vaginal Cancer (2) Waldenstrom Macroglobulinemia (1) Wilms Tumor (9)

Drug Dependence and Related Disorders (1 trials open to new patients)

Immune System (2 trials open to new patients)

Infectious Diseases (13 trials open to new patients)

Injuries (1 trials open to new patients)

Lungs and Breathing (1 trials open to new patients)

Mental Health (1 trials open to new patients)

Metabolic Problems (2 trials open to new patients)

Organ and Tissue Transplant (5 trials open to new patients)

Reproductive Health (3 trials open to new patients)

Surgical Studies (1 trials open to new patients)

Tumors (174 trials open to new patients)

B Cells--Tumors (1) Brain Tumor (10) Breast Tumor (1) Central Nervous System Embryonal Tumor (1) Colorectal Tumor (1) Congenital Mesoblastic Nephroma (1) Desmoid Tumor (1) Digestive System Neuroendocrine Neoplasm (1) Endocrine Gland Tumor (1) Ependymoma (8) Estrogen Receptor Positive Tumor (1) Gastrointestinal Stromal Tumor (6) Giant Cell Tumors (1) Head and Neck Tumor (5) Hematologic Neoplasms (2) INI1-negative Tumors (2) Locally Advanced Malignant Solid Neoplasm (3) Locally Advanced Solid Neoplasm (1) Low Grade Lung Neuroendocrine Neoplasm (1) Lung Tumor (3) Malignant Central Nervous System Neoplasm (1) Malignant Rhabdoid Tumor (2) Malignant Solid Neoplasm (22) Meningioma (2) Metastatic Malignant Solid Neoplasm (8) Mixed Mesodermal (Mullerian) Tumor (1) Myeloproliferative Neoplasms (7) Neoplasms (14) Neoplasm Metastasis (2) Neoplasm of Bone (1) Neoplasms by Histologic Type (1) Neoplasms by Site (2) Neoplasms, Colorectal (1) Neoplasms Pancreatic (1) Neuroendocrine Neoplasm (2) Neurofibromatosis Type 1 (3) Ovarian Tumor (2) Pediatric Central Nervous System Tumor (1) Peripheral Primitive Neuroectodermal Tumor (5) Refractory Central Nervous System Neoplasm (10) Refractory Central Nervous System Tumor (1) Refractory Malignant Solid Neoplasm (17) Refractory Neoplasm (1) Relapsed Central Nervous System Tumor (1) Renal Pelvis Neoplasms (2) Selected Tumors With Rhabdoid Features (1) Solid Tumor (112) Spinal Column Tumor (1) Squamous Intraepithelial Lesion (1) Stromal Neoplasm (1) Teratoma (4) Testicular Tumor (1) Tumor Types With FGFR2 Gene Fusions (1) Unresectable Solid Neoplasm (5) Ureteral Neoplasms (2) Urethral Neoplasms (2) Urinary Bladder Tumor (3) Urologic Neoplasms (2)

Other (189 trials open to new patients)

Abnormal DNA Repair (1) Acinar Cell Carcinoma (1) Activating Mutations (1) Activating RAS Mutation (1) Adenocarcinoma, Papillary (1) Adenoid Cystic Carcinoma (1) Adrenal Gland Pheochromocytoma (1) Adrenocortical Carcinoma (1) Adrenocortical Carcinoma (Part G) (1) Aggressive Fibromatosis (1) Aggressive NHL (a NHL) (1) ALK Fusion Protein Expression (1) ALK Gene Mutation (1) ALK Gene Rearrangement (3) ALK Gene Translocation (2) ALK Positive (2) ALK-positive Advanced NSCLC (1) Anal Canal Neuroendocrine Carcinoma (1) Anal Canal Undifferentiated Carcinoma (1) Antibiotic Allergy (1) Antibiotics (1) Apocrine Neoplasm (1) Appendix Mucinous Adenocarcinoma (1) ATM Gene Mutation (1) Autoimmune Disease (1) Barrett's Esophagus (1) Basal Cell Nevus Syndrome (1) BCR-ABL1 Fusion Protein Expression (1) BCR/ABL1 Fusion Protein Negative (1) Bladder Small Cell Neuroendocrine Carcinoma (1) Blood Clot (1) BRAF NP_004324.2:p.V600X (2) BRAF V600 Wild Type (2) Breast Screening (1) BRIP1 Gene Mutation (1) Bronchial Neoplasms (1) c-MET Gene Amplification (1) Cancer, Metastatic (1) Carcinoma (1) Carcinoma Breast (1) Carcinoma, Bronchogenic (1) Carcinoma, Ductal, Breast (1) Carcinoma, Neuroendocrine (1) Cardiotoxicity (1) Cardiovascular Complication (1) Castration Levels of Testosterone (4) CD19 Positive (1) CD20 Negative (1) CD20 Positive (1) CD22 Positive (1) CDKN2A-p16 Positive (1) Cervical Clear Cell Adenocarcinoma (1) CHEK2 Gene Mutation (1) Chemoembolization, Therapeutic (1) Chest Wall Disease (1) Chronic Lymphocytic Leukemia (14) Cognitive Dysfunction (1) Colonic Diseases (1) Complete Response (1) CTNNB1 Gene Mutation (1) Cutaneous T-Cell Lymphoma (2) Decision Support Systems, Clinical (1) Deep Vein Thrombosis (1) Deleterious ATM Gene Mutation (1) Deleterious RAD51C Gene Mutation (1) Deleterious RAD51D Gene Mutation (1) Desmoid-Type Fibromatosis (2) Differentiated Thyroid Gland Carcinoma (1) DLBCL (1) Dyspnea (1) EGFR Activating Mutation (2) EGFR Exon 19 Deletion Mutation (4) EGFR Exon 20 Insertion Mutation (2) EGFR Gene Amplification (1) EGFR Gene Mutation (2) EGFR NP_005219.2:p.G719X (2) EGFR NP_005219.2:p.L858R (4) EGFR NP_005219.2:p.L861Q (2) EGFR NP_005219.2:p.T790M (2) EGFR T790M Mutation Negative (1) Elevated Alpha-Fetoprotein (1) Epstein Barr Virus (2) ER Positive (1) Esophageal Neuroendocrine Carcinoma (1) Esophageal Undifferentiated Carcinoma (1) Esophagogastric Junction (1) Esophagogastric Junction Neoplasm (1) Essential Thrombocythemia (1) Exercise (1) Extensive Stage Lung Small Cell Carcinoma (1) Eyelid Diseases (1) EZH2 Gain of Function (1) EZH2 Gene Mutation (1) Fatigue (2) FGFR1 Gene Mutation (1) FGFR2 Amplification (1) FGFR2 Gene Mutation (2) FGFR3 Gene Mutation (1) FGFR4 Gene Mutation (1) Fibromyxoid Tumor (1) FIGO Stage III-IV (1) Gallbladder Adenocarcinoma (1) Gallbladder Carcinoma (1) Gastric Neuroendocrine Carcinoma (1) Gastric Undifferentiated Carcinoma (1) Gastro-esophageal Junction (GEJ) Cancer (1) Gastrointestinal Cancer (1) Gastrointestinal Disease (1) Gastrointestinal Neoplasms (2) Genitourinary Cancer (1) Giant Cell Carcinoma (1) Gut Microbiome (1) H3 K27M Negative (1) Hematologic Cancer (1) Hematologic Malignancies (2) Hematopoietic Cell Transplantation (3) Hemispheric (1) Hepatic Carcinoma (1) Hepatic Complication (1) Histiocytosis (4) HLA-A*0201 Positive Cells Present (1) HNSCC (1) Homologous Recombination Deficiency (1) HPV16 Positive (1) HRAS Mutant Tumor (1) Human Papillomavirus (5) Hypercalcemia (1) IDH1 Gene Mutation (3) IDH2 Gene Mutation (4) Infection (1) Intermediate Grade Lung Neuroendocrine Neoplasm (1) Intestinal Disease (1) Intestinal Neoplasms (1) Intestinal Neuroendocrine Carcinoma (1) Intracranial Neoplasm (1) Juvenile Xanthogranuloma (1) Kaposi's Sarcoma (6) KMT2A Gene Rearrangement (1) KRAS Gene Mutation (1) KRAS wt Allele (1) Lip SCC (1) Locally Advanced Chordoma (1) Locally Advanced Thymic Carcinoma (1) Loss of BRG1 Protein Expression (1) Loss of Heterozygosity (1) Loss of INI 1 Protein Expression (1) Lung Diseases (1) Lung Large Cell Carcinoma (1) Lung Neuroendocrine Neoplasm (1) Lung Non-Small Cell Squamous Carcinoma (1) Lung Non-Squamous Non-Small Cell Carcinoma (3) Lung Sarcomatoid Carcinoma (1) Lymphadenopathy (1) Lymphedema (1) Major Salivary Gland Carcinoma (1) Malignancies Multiple (1) Malignancies (1) Malignant Neoplastic Disease (1) Malignant Odontogenic Neoplasm (1) Malignant Ovarian Brenner Tumor (1) Malignant Testicular Sex Cord-Stromal Tumor (1) Malignant Uterine Neoplasm (1) Matched Targeted Therapy (1) Mesothelin Positive (1) MET Gene Alterations (1) Metastasis (1) Metastatic Chordoma (1) Metastatic Esophageal Carcinoma (1) Metastatic Lung Non-Small Cell Carcinoma (1) Metastatic Thymic Carcinoma (1) Metastatic Thyroid Gland Carcinoma (1) Microsatellite Instability (2) Microsatellite Stable (1) Minimal Residual Disease (2) Mismatch Repair Deficiency (1) Mismatch Repair Protein Proficient (1) MITF Positive (1) Monosomy 7 (1) Mucinous Cystadenocarcinoma (1) Mycosis Fungoides (3) Myelofibrosis (3) Myeloma (1) Myeloproliferative Disorders (1) Myeloproliferative Syndrome (1) Narcotic Use (1) Nasal Cavity Adenocarcinoma (1) Nasal Cavity Carcinoma (1) Nasopharyngeal Papillary Adenocarcinoma (1) Nasopharyngeal Undifferentiated Carcinoma (1) Nausea and Vomiting (1) NBN Gene Mutation (1) Neoplasm, Colorectal (1) Neoplasm Malignant (1) Neoplasms, Germ Cell and Embryonal (1) Neoplasms, Glandular and Epithelial (1) Neoplasms, Nerve Tissue (1) Neuroectodermal Tumors (1) Newly Diagnosed (1) NF1 Gene Mutation (1) NMYC Gene Amplification (1) Nodule Solitary Pulmonary (1) Non-Small-Cell Lung (1) Non-urothelial Bladder (1) Non-urothelial Upper Tract (1) NRAS wt Allele (1) NRG1 Fusion (1) NSCLC Harboring NRG1 Fusion (1) NSCLC, Recurrent (1) NSCLC Stage IIIB (1) NSCLC, Stage IIIC (1) NSCLC, Stage IV (1) NTRK1 Fusion Positive (1) NTRK2 Fusion Positive (1) NTRK3 Fusion Positive (1) NY-ESO-1 Positive (1) Oligometastasis (1) Oral Cancer (1) Oral Cavity Carcinoma (1) Oral Cavity Verrucous Carcinoma (1) Oropharyngeal Undifferentiated Carcinoma (1) Oropharynx Cancer, Metastatic (1) Oropharynx Cancer, Recurrent (1) Oropharynx Cancer, Stage III (1) Ovarian Seromucinous Carcinoma (2) Ovarian Undifferentiated Carcinoma (1) p16 Positive Neoplastic Cells Present (1) Paget's Disease (1) PALB2 Gene Mutation (1) Pancreatic Acinar Cell Carcinoma (1) Pancreatic Neuroendocrine Carcinoma (1) Paranasal Sinus Adenocarcinoma (1) Paranasal Sinus Carcinoma (1) Parathyroid Gland Carcinoma (1) Partial Response (1) PD-L1 Positive (1) Pharmacokinetics of Fluorouracil Bolus (5-FU) (1) Pharmacokinetics of Oxaliplatin (1) Pharmacokinetics of Zolbetuximab (1) Philadelphia Chromosome Positive (2) Pituitary Gland Carcinoma (1) Plasmacytoma (1) Plexiform Neurofibroma (1) Polycythemia Vera (1) Poorly Differentiated Thyroid Gland Carcinoma (2) Positive Axillary Lymph Node (1) Positive Lymph Node (1) Postmenopausal (1) Preoperative Aerobic Training (1) Primary Peritoneal (1) Progressive Disease (3) Prostate Neuroendocrine Neoplasm (1) Prostate Small Cell Carcinoma (1) PSA Level Greater Than 0.03 (1) PSA Level Greater Than Fifty (1) PSA Level Greater Than or Equal to Two (2) PSA Progression (4) Pseudomyxoma Peritonei (1) PTPN11 Gene Mutation (1) Pulmonary Disease (1) Quality of Life (1) RAD51 Gene Mutation (1) Radiation Toxicity (1) Rare Disorder (1) RB1 Positive (1) Refractory Germ-cell (1) Refractory Langerhans Cell Histiocytosis (7) Refractory Neurofibromatosis Type 1 (1) Refractory Osteosarcoma (8) Renal Mass (1) Resectable Pancreatic Ductal Adenocarcinoma (1) Respiratory Tract Disease (1) Respiratory Tract Neoplasms (1) Richter's Syndrome (2) ROS1 Fusion Positive (1) ROS1 Gene Mutation (1) ROS1 Gene Translocation (1) Salivary Cancer (1) Sdh (1) Seizures (1) Seminal Vesicle Adenocarcinoma (1) Serous Cystadenocarcinoma (1) Sinonasal Carcinoma (1) Small Intestinal Adenocarcinoma (1) SMARCA4 Gene Inactivation (1) SMARCB1 Gene Inactivation (1) SMARCB1 Gene Mutation (1) Spindle Cell Neoplasm (1) Splenomegaly (1) Stomach Neoplasms (1) Surgical Incision (1) Surgical Wound Infection (1) Surgical Wound, Recent (1) Systemic Mastocytosis (1) Testosterone Less Than 50 ng/dL (1) TFE3 Gene Translocation (1) TFEB Gene Translocation (1) Thoracic Neoplasms (1) Thymic Carcinoma (1) Thyroid Diseases (1) Thyroid Gland Follicular Carcinoma (2) Thyroid Gland Hurthle Cell Carcinoma (1) Thyroid Gland Papillary Carcinoma (2) TP53 wt Allele (3) Tracheal Carcinoma (1) Trisomy 21 Mosaicism (1) TSC1 Gene Mutation (2) TSC2 Gene Mutation (2) Tumors (1) Tumor Metastasis (1) Tumor Neck (1) Tumor Recurrence (1) Unmethylated MGMT Gene Promoter (1) Unresectable Chordoma (1) Unresectable Thymic Carcinoma (1) Ureter Adenocarcinoma (1) Ureter Small Cell Carcinoma (1) Urethral Adenocarcinoma (1) Vaginal Adenocarcinoma (2) Vaginal Adenosquamous Carcinoma (1) Vulvar Carcinoma (1) Wnt Positive (1)